BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AADvac1 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of AADvac1\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06957418-684@assetmemo.bio
DTSTAMP:20261121T004542Z
DTSTART;VALUE=DATE:20280831
DTEND;VALUE=DATE:20280901
SUMMARY:AADvac1: Phase 2 readout est. (NCT06957418)
DESCRIPTION:AADvac1\, phase 2\, Alzheimer's Disease.\nStudy: Alzheimer's Ta
 u Platform: Master Protocol\nEstimated primary completion: 31 August 2028.
  This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, an
 d it can move.\nDrug page: https://assetmemo.bio/drug/aadvac1#upcoming-eve
 nts\nRegistry record: https://clinicaltrials.gov/study/NCT06957418
URL:https://assetmemo.bio/drug/aadvac1#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07167966-684@assetmemo.bio
DTSTAMP:20261121T004542Z
DTSTART;VALUE=DATE:20280831
DTEND;VALUE=DATE:20280901
SUMMARY:AADvac1: Phase 2 readout est. (NCT07167966)
DESCRIPTION:AADvac1\, phase 2\, Alzheimer's Disease.\nStudy: Alzheimer's Ta
 u Platform: Regimen A - AADvac1\nEstimated primary completion: 31 August 2
 028. This is a ClinicalTrials.gov estimate\, not a confirmed readout date\
 , and it can move.\nDrug page: https://assetmemo.bio/drug/aadvac1#upcoming
 -events\nRegistry record: https://clinicaltrials.gov/study/NCT07167966
URL:https://assetmemo.bio/drug/aadvac1#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07217665-684@assetmemo.bio
DTSTAMP:20261121T004542Z
DTSTART;VALUE=DATE:20300928
DTEND;VALUE=DATE:20300929
SUMMARY:AADvac1: Phase 2 readout est. (NCT07217665)
DESCRIPTION:AADvac1\, phase 2.\nStudy: The Progressive Supranuclear Palsy C
 linical Trial Platform - Regimen A: AADvac1\nEstimated primary completion:
  28 September 2030. This is a ClinicalTrials.gov estimate\, not a confirme
 d readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/a
 advac1#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/
 NCT07217665
URL:https://assetmemo.bio/drug/aadvac1#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07173803-684@assetmemo.bio
DTSTAMP:20261121T004542Z
DTSTART;VALUE=DATE:20300928
DTEND;VALUE=DATE:20300929
SUMMARY:AADvac1: Phase 2 readout est. (NCT07173803)
DESCRIPTION:AADvac1\, phase 2.\nStudy: The Progressive Supranuclear Palsy C
 linical Trial Platform\nEstimated primary completion: 28 September 2030. T
 his is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and 
 it can move.\nDrug page: https://assetmemo.bio/drug/aadvac1#upcoming-event
 s\nRegistry record: https://clinicaltrials.gov/study/NCT07173803
URL:https://assetmemo.bio/drug/aadvac1#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
